文献速递流行病学与生物统计医学人工智能与信息学医学教育与科研方法

Quora社交问答平台上关于COVID-19疫苗临床试验讨论的特征分析

Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora.
PubMed 文献 · Trials · 2023-12-05

该研究于2021年10月 retrospectively 收集并分析Quora用户问答,采用归纳式内容编码,共收集1073个问题与7479个回答,其中763个问题、2548个回答与COVID-19疫苗临床试验相关。讨论集中于试验结果可信度、疫苗有效性与安全性、试验设计与监管、入组与代表性,并识别出四类参与障碍。结论认为这些讨论有助于识别公众与代表性不足群体的参与障碍,并支持未来外展策略设计。

要点

  • 共收集1073个问题与7479个回答,其中763个问题、2548个回答涉及COVID-19疫苗临床试验。
  • 讨论主题包括试验结果可信度、疫苗有效性与安全性、试验设计与监管、入组与代表性。
  • 识别出四类参与障碍:对少数族裔代表性的分歧、参与安全性担忧、缺乏参与知识、退出试验以获取已批准疫苗的疑问。

核心结论

  • 研究发现Quora上存在活跃的COVID-19疫苗临床试验相关讨论,包括少数族裔健康主题及由较小规模自我认同为少数族裔的在线用户发布的内容。
  • 研究结果可帮助识别公众与代表性不足群体的参与障碍,并支持未来外展策略的设计以助招募与包容性试验参与。

研究设计与样本

  • 研究于2021年10月 retrospectively 收集并分析Quora用户问答,采用归纳式内容编码方法。
  • 研究还检查用户公开可得的个人资料元数据以识别少数族裔用户,捕捉其经历、态度、主题与试验障碍讨论。
  • 共收集1073个问题与7479个回答。

主要发现

  • 763个问题与2548个回答被识别为与COVID-19疫苗临床试验相关。
  • 多数在线互动集中于询问问题及分享关于COVID-19疫苗试验的知识与观点。
  • 主要主题包括:判断临床试验结果是否可信、疫苗有效性与安全性、试验设计监管与疫苗平台、入组与时长及充分代表性。
  • 讨论的四大障碍包括:用户对临床试验是否需要不同种族和族裔少数群体代表性的分歧、参与时对试验安全性的担忧、缺乏如何参与试验的知识、参与者能否退出试验以获取已批准COVID-19疫苗的疑问。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minorities, were disproportionately impacted by illness, hospitalization, and death. Equity in clinical trials means that the participants in clinical trials represent the people who are most likely to have the health condition and need the treatment that the trial is testing. Infodemiology approaches examining user conversations on social media platforms have the potential to elucidate specific barriers and challenges related to clinical trial participation, including among racial and ethnic minority populations. MATERIALS AND METHODS: The study retrospectively collected and analyzed user question and answer posts from Quora in October 2021 using an inductive content coding approach. We also examined user's publicly available profile metadata to identify racial and ethnic minority users to capture their experiences, attitudes, topics, and discussions of barriers to COVID-19 vaccine trials. RESULTS: A total of 1073 questions and 7479 answers were collected. A total of 763 questions and 2548 answers were identified as related to COVID-19 vaccine clinical trials. The majority of these online interactions focused on asking questions and sharing knowledge and opinions about COVID-19 vaccine trials, including major topics related to: (a) interpreting whether clinical trial results could be trusted; (b) questions about vaccine efficacy and safety; (c) understanding trial design, regulatory considerations, and vaccine platforms; and (d) questions about trial enrollment, length, and adequate representation. Additionally, four major barriers discussed included: (i) disagreement from users regarding whether clinical trials require representation from different racial and ethnic minorities; (ii) concerns regarding the safety of trials when participating; (iii) lack of knowledge on how to participate in a trial; and (iv) questions of whether participants could withdraw from a trial to access an approved COVID-19 vaccine. CONCLUSIONS: Our study found active user discussions related to COVID-19 vaccine clinical trials on Quora, including those specific to minority health topics and those posted by a smaller group of self-identified racial and ethnic minority online users. Results from this study can help identify barriers to participation among the general public and underrepresented groups while also supporting the design of future outreach strategies to help with recruitment and inclusive trial participation.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xu Q, McMann TJ, Li J, et al. Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora. Trials. 2023. PMID: 38053216. doi:10.1186/s13063-023-07837-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。